Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | President | January 27, 2022 | August 01, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date January 27, 2022 · Filed August 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,857 |
Ending reported balance
After 2023-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-01-27 · Grant · Acquired 50,000 · Balance 74,857 F1: The shares result from the vesting of performance-based restricted stock which vested on January 27, 2022. Each restricted stock share is equivalent to one share of the Company's common stock. Row 2 · 2023-07-28 · Grant · Acquired 50,000 · Balance 124,857 F2: The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares result from the vesting of performance-based restricted stock which vested on January 27, 2022. Each restricted stock share is equivalent to one share of the Company's common stock.
F2: The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2023 Filed Aug 1, 2023 21:14 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001362118-23-000049 · primary_doc.xml · nonDerivative · entry 2 Mironov Alexander · CIK 0001877065 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,857 F2 · price: The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock. Read SEC document |
| January 27, 2022 Filed Aug 1, 2023 21:14 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001362118-23-000049 · primary_doc.xml · nonDerivative · entry 1 Mironov Alexander · CIK 0001877065 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,857 F1 · price: The shares result from the vesting of performance-based restricted stock which vested on January 27, 2022. Each restricted stock share is equivalent to one share of the Company's common stock. Read SEC document |
| January 11, 2022 Filed Feb 15, 2022 00:38 UTC | LifeMD, Inc. LFMD · Entity 6521 | OtherCommon Stock | 22,000 | $1.75 | $38,500.00 |
DisclosureSEC source: 0001362118-22-000016 · primary_doc.xml · nonDerivative · entry 1 Mironov Alexander · CIK 0001877065 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,857 Read SEC document |
| July 19, 2021 Filed Feb 15, 2022 00:25 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseWarrants to Purchase Common Stock · Derivative | 22,000 | $0.83 Strike: $1.75 | $18,183.00 |
DisclosureSEC source: 0001362118-22-000015 · primary_doc.xml · derivative · entry 1 Mironov Alexander · CIK 0001877065 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2022-01-12 Read SEC document |
| June 10, 2021 Filed Sep 10, 2021 21:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $14.04 | $0.00 |
DisclosureSEC source: 0001362118-21-000036 · primary_doc.xml · derivative · entry 2 Mironov Alexander · CIK 0001877065 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2026-06-09 F1 · derivative.exercise_date: 1/36th of the shares vest on the date of grant. Subject to the terms of the Option Agreement and subject to the Reporting Person continuing to perform services for the Company on each vesting date, the remaining 35/36th of the shares shall vest ratably and become exercisable in equal monthly tranches on the 11th day of each calendar month, over 35 consecutive months, commencing on July 11, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.